- Home
- ASH vs JANX Comparison
ASH vs JANX Comparison
Compare ASH & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASH
- JANX
- Stock Information
- Founded
- ASH 1924
- JANX 2017
- Country
- ASH United States
- JANX United States
- Employees
- ASH N/A
- JANX N/A
- Industry
- ASH Specialty Chemicals
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- ASH Consumer Discretionary
- JANX Health Care
- Exchange
- ASH Nasdaq
- JANX Nasdaq
- Market Cap
- ASH 3.3B
- JANX 3.0B
- IPO Year
- ASH N/A
- JANX 2021
- Fundamental
- Price
- ASH $72.74
- JANX $39.88
- Analyst Decision
- ASH Buy
- JANX Strong Buy
- Analyst Count
- ASH 7
- JANX 11
- Target Price
- ASH $101.00
- JANX $83.09
- AVG Volume (30 Days)
- ASH 470.0K
- JANX 971.4K
- Earning Date
- ASH 01-28-2025
- JANX 03-07-2025
- Dividend Yield
- ASH 2.22%
- JANX N/A
- EPS Growth
- ASH 1.05
- JANX N/A
- EPS
- ASH 3.35
- JANX N/A
- Revenue
- ASH $2,113,000,000.00
- JANX $13,049,000.00
- Revenue This Year
- ASH N/A
- JANX $39.66
- Revenue Next Year
- ASH $4.16
- JANX N/A
- P/E Ratio
- ASH $21.78
- JANX N/A
- Revenue Growth
- ASH N/A
- JANX 54.12
- 52 Week Low
- ASH $68.15
- JANX $7.79
- 52 Week High
- ASH $102.50
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- ASH 49.66
- JANX 31.06
- Support Level
- ASH $69.61
- JANX $39.95
- Resistance Level
- ASH $73.31
- JANX $47.46
- Average True Range (ATR)
- ASH 1.42
- JANX 3.73
- MACD
- ASH 0.56
- JANX -1.27
- Stochastic Oscillator
- ASH 79.05
- JANX 5.73
About ASH Ashland Inc.
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.